Net Deals Web Search

Search results

1. Results From The WOW.Com Content Network

2. 6 Foods to Avoid While on Ozempic, According to Doctors - AOL

   www.aol.com/6-foods-avoid-while-ozempic...

   Fresh fruits that are considered diabetes-friendly due to sugar content, which includes apples, berries, peaches, pears and more. Vegetables of all kinds, including fiber-rich leafy greens. Whole ...

3. What Endocrinologists Want You to Know About Rybelsus and Ozempic

   www.aol.com/endocrinologists-want-know-rybelsus...

   Ozempic is a once-weekly injection used along with diet and exercise to improve blood sugar in adults with type 2 diabetes. The medication may help you lose weight, though that’s not its intent ...

4. What Doctors Want You to Know About Weight Loss Drugs and ...

   www.aol.com/doctors-want-know-weight-loss...

   July 12, 2024 at 5:30 AM. New research links a rare and blinding eye condition to semaglutide. Semaglutide is the active ingredient in Ozempic and Wegovy. Doctors recommend that people don't panic ...

5. Cagrilintide/semaglutide - Wikipedia

   en.wikipedia.org/wiki/Cagrilintide/semaglutide

   HbA1c was significantly improved compared to cagrilintide alone and non-significantly better than semaglutide alone. In a Phase II trial, weight loss averaged -15.6 percent after 32 weeks, making CagriSema comparable in efficacy to tirzepatide. A future trial sponsored by Novo Nordisk is comparing tirzepatide and CagriSema head-to-head.

6. Semaglutide - Wikipedia

   en.wikipedia.org/wiki/Semaglutide

   Semaglutide is an antidiabetic medication used for the treatment of type 2 diabetes and an anti-obesity medication used for long-term weight management. [19] [20] [21] It is a peptide similar to the hormone glucagon-like peptide-1 (GLP-1), modified with a side chain .

7. GLP-1 receptor agonist - Wikipedia

   en.wikipedia.org/wiki/GLP-1_receptor_agonist

   GLP-1 agonists have shown antidepressant and neuroprotective effects. They can also be used as treatment for the negative metabolic consequences of second-generation antipsychotics such as obesity. Reward system disorders. GLP-1 agonists are under development for substance use disorder, a condition with few pharmacological treatment options ...